南水北调中线总干渠藻类的生态调度

南水北调中线总干渠无在线调蓄水库,对藻类生态调度过程中出现的问题开展生态调度实现策略和实施方式研究。主要实现策略包括:划定自身的调蓄区,隔离生态调度对下游的影响;采用高效的渠池运行方式,减少生态调度时蓄量的反复调整;综合考虑安全、快速、平稳等需求,设定生态调度实施进程和方式。具体实施方式包括:将总干渠划分为流速调控区、调蓄区和正常运行区,分别实施等体积、控制蓄量和闸前常水位方式运行;将生态调度过程划分为充水阶段和泄水阶段,基于流速调控目标值、持续时长和水位降幅约束条件,确定各阶段时长和各分区的闸门群调控方案等。基于2018年3月输水工况,采用明渠一维非恒定流模型,仿真总干渠上游15个渠池的藻类生态调度过程。结果表明,生态调度可在3.5 d内完成,各渠池的平均流速由0.48 m/s增至0.93 m/s,持续时间超过2 h。在整个生态调度过程中,水位变化平稳,水位变幅符合安全阈值要求,下游渠道的正常运行未受生态调度明显影响。     

草原石林：东北亚早白垩世花岗岩伸展穹隆和岩浆成矿爆发的地质遗迹及其形成过程

东北亚地区至少发育9个大型草原石林,属花岗岩石林的一种,是东北亚早白垩世巨量伸展和第四系冰川、风化作用的共同产物,主要特点是发育密集的近水平节理。本文通过整理岩浆岩专题填图和构造研究发现,这些石林的主体是早白垩世东北亚地区巨量伸展过程中形成众多的不对称花岗岩穹隆或同减薄岩体,岩体边部发育韧性剪切带,核部发布近水平岩浆流动面理,伸展和岩浆多期侵位导致与成矿密切相关的岩浆热液大量上涌,岩体抬升至地表,沿岩浆面理发育密集的近水平节理和部分垂直节理,后期沿这些构造面理发生的物理风化和化学作用(包括风蚀、冰川以及盐风化等)造就了千奇百怪的形态。草原石林是花岗岩地貌中的“另类”,不仅具有指示东北亚地区花岗岩形成时代(早白垩世)的特点,也是寻找晚中生代中国北方大规模成矿的良好标志体,而且风化形成的千姿百态的景色极具观赏价值,可以作为整个蒙古草原地区和大兴安岭南段地区特色的地学科普和生态旅游资源。     

电感耦合等离子体质谱法测定大气降水中钠的不确定度评定

采用电感耦合等离子体质谱仪测定大气降水样品中的钠元素，并依据不确定度的评定与表示方法对分析过程中存在的不确定度来源如：标准溶液配制、校准曲线拟合、样品重复测定等各个环节进行探讨和评定，找出影响不确定度的主要因素。最终给出降水样品的合成扩展不确定度，降水样品的钠的浓度表示为(3.934±0.550)mg/L,k=2,从而使得分析结果的表达更加准确可靠。     

国内外己内酰胺供需现状及发展前景

分析了国内外己内酰胺的生产消费现状及发展前景.2019年,世界己内酰胺的生产能力为811.9万t/a,消费量为640.0万t,预计2024年消费量将达到约750.0万t.2019年,我国己内酰胺的生产能力为419.0万t/a,消费量为337.2万t,预计2024年消费量将达到约420.0万t.提出了我国己内酰胺行业今后的发展建议.     

α钛富氧层增厚动力学模型

为了实现在工业化生产中对α钛富氧层厚度预测和控制,通过实验研究α钛富氧层在高温空气环境中的形成及增厚过程,讨论热处理温度和时间的影响作用,建立高温(750~850℃)空气环境下关于温度、时间的富氧层增厚动力学模型。结果表明:当恒温热处理温度为750~850℃时,α钛富氧层厚度x与保温时间t0.5呈正比例关系,且升高热处理温度可显著提高富氧层增厚速度。在此温度范围内,氧原子的扩散激活能约为203473 J/mol,计算曲线与实验数据吻合性较好。结合文献中已有的扩散系数方程和实验测得的富氧层厚度数据,推导得到5个富氧层增厚动力学方程,其中3个方程的计算曲线与实验数据吻合性较好,可为实际生产中预估富氧层厚度提供理论支持。     

碳纳米管在合成橡胶中的应用研究进展

碳纳米管独特的结构使其具有超高的强度、极大的韧性、独特的导电和导热等性能,作为增强材料在橡胶工业中具有重要的应用。介绍碳纳米管单独使用增强丁苯橡胶、乙丙橡胶、丁腈橡胶以及聚异戊二烯橡胶等单一胶种以及增强多种橡胶或者与其他补强材料并用的应用研究进展,指出今后应继续探索碳纳米管的改性方法,提高碳纳米管在橡胶基体中的分散性,增强其与橡胶基体之间的相互作用;进一步探讨碳纳米管与其他助剂的协同作用机理,完善碳纳米管/合成橡胶复合材料的制备技术。     

Non-Halogenated-Solvent Processed and Additive-Free Tandem Organic Solar Cell with Efficiency Reaching 16.67%

Organic solar cells (OSCs) have recently reached a remarkably high efficiency and become a promising technology for commercial application. However, OSCs with top efficiency are mostly processed by halogenated solvents and with additives that are not environmentally friendly, which hinders large-scale manufacture. In this study, high-performance tandem OSCs, based on polymer donors and two small-molecule acceptors with different bandgaps, are fabricated by solution processing with non-halogenated solvents without additive. Importantly, the two active layers developed from non-halogenated solvents show better phase segregation and charge transport properties, leading to superior performance than halogenated ones. As a result, a tandem OSC with high efficiency of up to 16.67% is obtained, showing unique advantages in future massive production.     

Enzyme-Activated Prodrug-Based Smart Liposomes Specifically Enhance Tumor Hemoperfusion with Efficient Drug Delivery to Pancreatic Cancer Cells and Stellate Cells

Tumor-specific enhanced delivery of chemotherapeutics and modulators to tumor cells and activated pancreatic stellate cells (aPSCs), respectively, represents safer and more effective therapy for pancreatic cancer. Herein, a membrane type 1-matrix metalloproteinase (MT1-MMP)-cleavable spacer is used to assemble low-density cRGDfK onto thermosensitive liposomes loaded with phosphorylated calcipotriol (PCAL) and doxorubicin (DOX), yielding MR-T-PD. The liposome-linked cRGDfK prodrug on MR-T-PD surface is first activated by MT1-MMP, which is selectively expressed on tumor endothelial cells, to release cRGDfK. The free cRGDfK specifically promotes tumor angiogenesis, leading to 3.4-fold higher accumulation and a wider distribution of MR-T-PD in tumors. Furthermore, MR-T-PD rapidly releases PCAL and DOX into the interstitium under heat treatment. The released DOX enters tumor cells to induce apoptosis, whereas the PCAL prodrug is converted to CAL by alkaline phosphatase on the surface of aPSCs; CAL can then enter aPSCs to induce quiescence and promote the antitumor effect of DOX. Finally, by enhancing the exposure of DOX and CAL to tumor cells and aPSCs, respectively, in a tumor-specific manner, MR-T-PD exerts superior efficacy (a 5.9-fold decrease in tumor weight) without causing additional side effects. Overall, this prodrug-based smart liposome system represents a promising paradigm for pancreatic cancer therapy.